Novel Coronavirus (SARS-CoV-2/COVID-19)
New research from the Center for Disease Control and Prevention indicates that by early fall 2022, an overwhelming percentage of American adults had antibodies to SARS-CoV-2, the virus that causes COVID-19.
The Centers for Medicare & Medicaid Services (CMS) May 31 released a final rule to better align certain regulatory requirements with the end of the public health emergency (PHE), including rescission of the health care worker vaccine mandate.
The Centers for Medicare and Medicaid Services released a FAQ regarding Consolidated Appropriations Act changes for states redetermining Medicaid enrollee eligibility due to the March 31 end of the COVID-19 pandemic’s continuous enrollment requirement.
Accurate coding is critical: AHA's ICD-10-CM FAQs address pneumonia icd10 & dizziness icd10 for precise COVID-19 documentation.
The Department of Health and Human Services yesterday released a fact sheet reviewing how the May 11 end of the COVID-19 public health emergency will affect the flexibilities the declaration enabled.
The Centers for Disease Control and Prevention (CDC) May 8 updated its COVID-19 infection control and prevention guidelines.
After the COVID-19 public health emergency ends on May 11, the Centers for Disease Control and Prevention will use COVID-19-associated hospital admission levels as the primary indicator to guide community and personal decisions related to risk and prevention behaviors.
The Centers for Medicare & Medicaid Services (CMS) May 1 published a memorandum directed to state surveyors outlining the regulatory requirements set to be reinstated when the public health emergency (PHE) ends.
he American Hospital Association, Association of American Medical Colleges, America’s Essential Hospitals and the Federation of American Hospitals are pleased to invite you to a call with the Centers for Medicare & Medicaid Services (CMS).
In a study of adults hospitalized between February 2022 and February 2023, when the omicron variant predominated, monovalent mRNA vaccination was 76% effective at preventing COVID-19-associated invasive mechanical ventilation and death up to 6 months after the last dose and 56% effective at least…